OxyPlus Secures $4,507,000 New Funding

  • Feed Type
  • Date
    6/30/2009
  • Company Name
    OxyPlus
  • Mailing Address
    300 Market Str Boston, MA 02135
  • Company Description
    OxyPlus is a developer of small molecule compounds for the treatment of cardiovascular issues and cancer.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $4,507,000
  • Transaction Round
    Undisclosed
  • Proceeds Purposes
    Proceeds purposes were not disclosed.
  • M&A Terms
  • Venture Investor
    Index Ventures

Trending on Xconomy